- Home
- LH vs LII Comparison
LH vs LII Comparison
Compare LH & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LH | LII |
|---|---|---|
| Founded | 1971 | 1895 |
| Country | United States | United States |
| Employees | 70000 | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9B | 19.5B |
| IPO Year | 2005 | 1999 |
Fundamental Metrics
Financial Performance| Metric | LH | LII |
|---|---|---|
| Price | $264.29 | $478.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 13 |
| Target Price | $308.30 | ★ $596.75 |
| AVG Volume (30 Days) | ★ 508.2K | 372.7K |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | 1.08% | ★ 1.09% |
| EPS Growth | ★ 18.33 | 1.11 |
| EPS | 10.46 | ★ 22.79 |
| Revenue | ★ $13,951,700,000.00 | $5,195,300,000.00 |
| Revenue This Year | $8.36 | $6.90 |
| Revenue Next Year | $4.73 | $5.69 |
| P/E Ratio | $25.43 | ★ $21.04 |
| Revenue Growth | ★ 7.25 | N/A |
| 52 Week Low | $209.38 | $443.19 |
| 52 Week High | $293.72 | $689.44 |
Technical Indicators
Market Signals| Indicator | LH | LII |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 34.26 |
| Support Level | $258.99 | $443.19 |
| Resistance Level | $268.11 | $571.67 |
| Average True Range (ATR) | 5.78 | 16.65 |
| MACD | -1.73 | -6.70 |
| Stochastic Oscillator | 5.16 | 11.54 |
Price Performance
Historical ComparisonAbout LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
About LII Lennox International Inc.
Lennox International manufacturers and distributes heating, ventilating, air conditioning, and refrigeration products for the North American replacement (75% of sales) and new construction (25% of sales) markets. Residential HVAC (home comfort solutions) accounted for 67% of sales and commercial HVAC (building climate solutions) accounted for the remaining 33% of sales. To be clear, Lennox's commercial exposure is what its peers refer to as "residential and light commercial," lacks the scale and complexity of what is referred to as an "applied" solution. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand.